Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print

Industry News

Related Searches:

Filter by:

September 12, 2012
Four newly approved sites expand presence in U.S. market   Read More »
September 12, 2012
Designed to overcome challenges of 28-day method   Read More »
September 11, 2012
Adds granulation equipment at Sligo site   Read More »
September 11, 2012
To manufacture and store bulk antigen for pandemic flu strains   Read More »
September 11, 2012
To develop autoimmune drug for Chinese market   Read More »
September 11, 2012
Adds reactor capacity and isolation equipment   Read More »
September 6, 2012
Expands diagnostic capabilities for research services   Read More »
September 5, 2012
Patheon to focus on core competencies   Read More »
September 5, 2012
Appoints business development director   Read More »
September 5, 2012
Supports Class 4 HPAPI’s   Read More »
September 4, 2012
Will make Prurisol for Phase II/III psoriasis trials   Read More »
September 4, 2012
Will focus on CNS Disorders   Read More »
September 4, 2012
To provide cell line development through maxXpress service   Read More »
August 31, 2012
Will pay $181 million to resolve claims   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On